Synopsys financials
$415.09−0.60%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q3 '26 Jul 31 | Q2 '26 Apr 30 | Q1 '26 Jan 31 | Q4 '25 Oct 31 | Q3 '25 Jul 31 | Q2 '25 Apr 30 | Q1 '25 Jan 31 | Q4 '24 Oct 31 | Q3 '24 Jul 31 | Q2 '24 Apr 30 | Q1 '24 Jan 31 | Q4 '23 Oct 31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.48B | $2.28B | $2.41B | $2.25B | $1.74B | $1.60B | $1.46B | $1.64B | $1.53B | $1.45B | $1.51B | $1.47B |
| Gross profit | $1.80B | $1.65B | $1.77B | $1.60B | $1.36B | $1.29B | $1.19B | $1.26B | $1.24B | $1.15B | $1.24B | $1.23B |
| Gross margin | 72.6% | 72.3% | 73.5% | 71.0% | 78.1% | 80.2% | 81.4% | 77.1% | 80.9% | 79.4% | 82.4% | 83.6% |
| Operating income | $357.5M | $120.4M | $203.0M | $121.4M | $165.3M | $376.4M | $251.8M | $310.8M | $360.2M | $332.1M | $352.6M | $424.2M |
| Net income | $545.8M | $17.1M | $65.0M | $448.7M | $242.5M | $345.3M | $295.7M | $1.11B | $408.1M | $292.1M | $449.1M | $349.2M |
| Net margin | 22.0% | 0.8% | 2.7% | 19.9% | 13.9% | 21.5% | 20.3% | 68.1% | 26.7% | 20.1% | 29.7% | 23.8% |
| Diluted EPS | $2.84 | $0.09 | $0.34 | $2.38 | $1.50 | $2.21 | $1.89 | $7.12 | $2.61 | $1.88 | $2.89 | $2.24 |
| EBITDA | $814.5M | $692.8M | $772.0M | $570.5M | $279.7M | $425.3M | $299.8M | $425.7M | $416.5M | $393.1M | $415.5M | $422.8M |
| Operating cash flow | $812.8M | $628.9M | $856.8M | $639.7M | $671.0M | $275.4M | -$67.5M | $562.8M | $455.4M | $476.6M | -$87.8M | $326.1M |
| Free cash flow | $746.3M | $574.7M | $821.5M | $605.2M | $632.4M | $219.8M | -$108.2M | $542.1M | $415.4M | $438.2M | -$128.2M | $273.0M |
| Diluted shares | 192.3M | 192.1M | 190.8M | 188.7M | 161.7M | 156.1M | 156.2M | 156.5M | 156.1M | 155.8M | 155.3M | 156.0M |
Balance sheet
| Period end | Jul 31 | Apr 30 | Jan 31 | Oct 31 | Jul 31 | Apr 30 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $3.61B | $2.41B | $2.13B | $2.89B | $2.53B | $14.12B |
| Short-term investments | $1.4M | $72.0M | $73.9M | $72.9M | $67.2M | $144.8M |
| Total debt | $10.04B | $10.04B | $10.04B | $13.48B | $14.34B | $10.05B |
| Total assets | $47.73B | $46.89B | $47.24B | $48.22B | $48.23B | $23.76B |
| Total liabilities | $16.57B | $16.41B | $16.69B | $19.90B | $20.62B | $13.84B |
| Shareholders' equity | $31.15B | $30.48B | $30.55B | $28.33B | $27.61B | $9.92B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology